Skip to main content

Table 4 Summary of grade 3/4 toxicity in patients treated by triplet chemotherapy plus anti-EGFR agents

From: Efficacy and safety of triplet chemotherapy plus anti-EGFR agents in metastatic colorectal cancer: a systematic review and meta-analysis

Author

Total

Neutropenia

FN

Thrombopnia

Diarrhea

Nausea/vomiting

Anorexia

Stomatitis

Asthenia

Skin toxicity

Neurotoxicity

HFS

Hypomagnesemia

Others

C Garufi

43

2

-

-

15

4

-

-

5

6

-

-

-

3

Sougklakos, Ia

30

7

NA

NA

16

NA

NA

NA

NA

13

5

NA

NA

NA

ERIC ASSENAT

42

16

2

5

22

4

10

-

13

14

8

4

-

4

Z Saridaki

30

7

1

2

16

5

-

3

-

1

-

1

-

1

Folprecht, Ga

28

13

NA

NA

NA

NA

NA

NA

NA

5

NA

NA

NA

NA

Fornaro, L

37

18

2

-

13

5

-

5

10

5

3

1

5

-

Bendell, J. C

15

2

-

1

5

1

2

-

3

3

-

1

1

2

Cremolini, C

116

36

4

-

21

3

4

7

11

18

-

-

-

-

D Modest

63

10

-

-

16

6

-

6

5

9

2

4

3

17

Ogata, T

17

10

-

-

2

1

-

-

-

-

-

-

2

-

E. Samalina

70

15

2

NA

22

NA

NA

NA

NA

NA

NA

NA

NA

NA

Deng, Y

67

21

2

1

5

1

-

1

1

-

3

-

-

6

Akihito Tsujia

173

NA

NA

NA

21

NA

NA

NA

NA

21

NA

NA

7

NA

Total

731

157

13

9

174

30

16

22

48

95

21

11

18

33

  1. aToxicity profile uncompleted; FN febrile neutropenia, HFS hand/foot syndrome, NA not available